A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/715 (2006.01) A61K 9/00 (2006.01) A61K 31/73 (1990.01)
Patent
CA 2129238
2129238 9315744 PCTABS00024 Compositions and methods useful for protecting human or animal eye cell layers and tissues exposed to trauma, e.g., during surgery, are disclosed. In one embodiment, the method comprises administering a protective amount of an ophthalmically acceptable aqueous composition containing a first alkali metal and/or alkaline earth metal hyaluronate fraction having a molecular weight of at least about 300,000, for example, in the range of about 500,000 to about 750,000, and a second alkali metal and/or alkaline earth metal hyaluronate fraction having a molecular weight of less than about 200,000, for example, in the range of about 25,000 to about 175,000, to eye cell layers and tissues prior to the exposure to the trauma.
Allergan Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Bimodal molecular weight hyaluronate formulations and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bimodal molecular weight hyaluronate formulations and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bimodal molecular weight hyaluronate formulations and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1589517